Dermatomyositis

A type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.

Purpura

Purpura (from Latin: purpura, meaning \"purple\") is the appearance of red or purple discolorations on the skin that do not blanch on applying pressure. They are caused by bleeding underneath the skin. This term refers to an abnormally increased susceptibility to developing purpura. Purpura are larger than petechiae.


Total: 5

                      


(per page)
PMID (PMCID)
21911331
(3184519)
FEMALE Infant, Newborn
Fetal adrenal suppression due to maternal corticosteroid use: case report.
Kurtoglu S, Sarc D, Akn MA, Daar G, Korkmaz L, Memur .
J Clin Res Pediatr Endocrinol. 2011;3(3):160-2.
idiopathic thrombocytopenic purpura (ITP), Crohn's disease, systemic lupus erythematosus, dermatomyositis, scleroderma, Addison's disease and hyperemesis gravidarum, HELLP syndrome.
11254245
FEMALE Middle Aged
Induction of remission with intravenous immunoglobulin and cyclophosphamide in steroid-resistant Evans' syndrome associated with dermatomyositis.
Chang DK, Yoo DH, Kim TH, Jun JB, Lee IH, Bae SC, Kim IS, Kim SY.
Clin Rheumatol. 2001;20(1):63-6.
A 59-year-old woman, who had been taking high-dose prednisolone for a month and cyclosporin for 10 days for dermatomyositis, developed purpura on the left popliteal fossa.
10349207
FEMALE
Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma.
Moccia F.
Ann Ital Med Int. 1998;13(4):240-3.
We recently observed a patient with chronic C hepatitis who developed first autoimmune thrombocytopenic purpura and subsequently dermatomyositis.
10349207
FEMALE
Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma.
Moccia F.
Ann Ital Med Int. 1998;13(4):240-3.
Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma.
10349207
FEMALE
Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma.
Moccia F.
Ann Ital Med Int. 1998;13(4):240-3.
Our results could be the consequence of the association of immunosuppressive therapy intensive enough to control the autoimmune thrombocytopenic purpura and dermatomyositis with alpha-interferon whose antiviral capacity may have been able to prevent re-exacerbation of the hepatitis.